Loading…
Seres Therapeutics, Inc. is projected to rise to $8.32 by 2027, a +36% move from its current price of $6.11. MCRB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $5.83 | $6.11 | $6.40 | 0.00% |
| Jul 14 | $5.72 | $6.11 | $6.53 | 0.00% |
| Jul 15 | $5.63 | $6.11 | $6.63 | 0.00% |
| Jul 16 | $5.56 | $6.11 | $6.71 | 0.00% |
| Jul 17 | $5.50 | $6.11 | $6.79 | 0.00% |
| Jul 18 | $5.45 | $6.11 | $6.85 | 0.00% |
| Jul 19 | $5.40 | $6.11 | $6.92 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.40 | $6.11 | $6.92 | 0.00% |
| Week 2 | $5.13 | $6.11 | $7.28 | -0.01% |
| Week 3 | $4.93 | $6.11 | $7.57 | -0.01% |
| Week 4 | $4.77 | $6.11 | $7.83 | -0.02% |
| Week 5 | $4.63 | $6.11 | $8.06 | -0.02% |
| Week 6 | $4.51 | $6.11 | $8.28 | -0.02% |
| Week 7 | $4.40 | $6.11 | $8.48 | -0.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seres Therapeutics, Inc. is a clinical-stage healthcare company focused on developing biotherapeutics for serious diseases. It develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Seres Therapeutics, Inc. (MCRB) trades at $6.11 per share and has a market cap of $59.17M. It ranks 4453. The 30-day technical picture shows bearish sentiment with RSI14 at 40, and the moving averages are SMA50 at $7.23 and SMA200 at $12.33.
A major floor 32.8% below — a decisive break under it would weaken the trend.
The nearest floor, 8.0% below — buyers have tended to step in here.
The nearest ceiling, 33.2% above — a clean break opens room to run.
A major ceiling 55.8% above — clearing it would confirm fresh momentum.
Key MCRB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCRB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.17 | Sell | $6.91 | Sell |
| MA 10 | $7.43 | Sell | $7.11 | Sell |
| MA 20 | $6.91 | Sell | $7.11 | Sell |
| MA 50 | $7.23 | Sell | $7.44 | Sell |
| MA 100 | $7.98 | Sell | $8.65 | Sell |
| MA 200 | $12.33 | Sell | $10.69 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.79 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -85.53 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -13.33 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | 0.14 | Buy |
| Ultimate (7,14,28) | 28.81 | Buy |
| Momentum (10) | -0.73 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 6.68 | Sell |
| ADX (14) | 18.73 | Neutral |
| ATR (14) | 0.32 | Info |
The stock’s 30-day price range runs from $4.48 to $8.32, with a support at $5.62 and a resistance at $8.14. Annualized volatility sits at 90%. RSI is 40, and the price is currently trading near the 50-day average at $7.23 while well below the 200-day average at $12.33.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.62 | $6.11 | $8.46 | 0% | Neutral | |
| $6.18 | $8.32 | $12.06 | +36% | Bullish | |
| $6.70 | $9.50 | $14.59 | +55% | Bullish | |
| $5.79 | $8.57 | $13.77 | +40% | Bullish | |
| $5.48 | $8.45 | $14.07 | +38% | Bullish | |
| $5.27 | $8.43 | $14.49 | +38% | Bullish | |
| $5.38 | $8.90 | $15.75 | +46% | Bullish | |
| $6.35 | $10.88 | $19.73 | +78% | Bullish | |
| $7.08 | $12.52 | $23.24 | +105% | Bullish | |
| $7.62 | $13.91 | $26.37 | +128% | Bullish | |
| $8.20 | $17.37 | $35.95 | +184% | Bullish | |
| $12.65 | $28.11 | $64.64 | +360% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.62 | $6.11 | $7.76 | +0.00% |
| August 2026 | $5.38 | $6.48 | $8.09 | +6.04% |
| September 2026 | $5.01 | $6.11 | $7.77 | -5.74% |
| October 2026 | $4.96 | $6.11 | $7.89 | -0.03% |
| November 2026 | $5.18 | $6.44 | $8.43 | +5.44% |
| December 2026 | $5.10 | $6.39 | $8.46 | -0.78% |
Click any year to see its month-by-month MCRB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MCRB to range from $5.62 to $8.46 through 2026. The $6.11 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MCRB price prediction for 2027 points to an average of $8.32 (low $6.18, high $12.06) — a potential gain of +36% on today's $6.11. Momentum favours further upside here.
In 2028, MCRB is projected to trade between $6.70 and $14.59, averaging $9.50 — a potential gain of +55% from today's $6.11. That is up +14% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Seres Therapeutics, Inc.'s 2029 outlook centres on $8.57, within a $5.79 to $13.77 range. That is -10% versus the projected 2028 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2030, MCRB could reach as high as $14.07, with a base case around $8.45 and support toward $5.48 — roughly +38% from $6.11. Buyers look set to stay in control over this stretch.
Expect MCRB to range from $5.27 to $14.49 through 2031. The $8.43 average target implies a +38% move from current prices. That is 0% versus the projected 2030 average. Momentum favours further upside here.
The MCRB price prediction for 2032 points to an average of $8.90 (low $5.38, high $15.75) — a potential gain of +46% on today's $6.11. Buyers look set to stay in control over this stretch.
In 2033, MCRB is projected to trade between $6.35 and $19.73, averaging $10.88 — a potential gain of +78% from today's $6.11. That is up +22% on the projected 2032 average. Momentum favours further upside here.
Seres Therapeutics, Inc.'s 2034 outlook centres on $12.52, within a $7.08 to $23.24 range. That is up +15% on the projected 2033 average. That marks a +105% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MCRB could reach as high as $26.37, with a base case around $13.91 and support toward $7.62 — roughly +128% from $6.11. Momentum favours further upside here.
Expect MCRB to range from $8.20 to $35.95 through 2040. The $17.37 average target implies a +184% move from current prices. That is up +25% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MCRB price prediction for 2050 points to an average of $28.11 (low $12.65, high $64.64) — a potential gain of +360% on today's $6.11. Momentum favours further upside here.
Investing $1,000 in MCRB today (≈ 163.666121 MCRB) could be worth
$4,599.97
+$3,599.97 (+360%) by 2050 · US Dollar
Based on the average projected MCRB price of $28.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCRBwould be worth at today's price.
$1,000 invested in MCRB on Jul 10, 2025 (≈ 80.971657 MCRB) would be worth
$494.74
-$505.26 (-50.5%) today · 0.49× · US Dollar
Based on a MCRB entry price of $12.35 vs. today's $6.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.74 | $789.41 | -21.1% |
| 1 month ago | $6.49 | $941.45 | -5.9% |
| 3 months ago | $8.32 | $734.38 | -26.6% |
| 6 months ago | $15.84 | $385.73 | -61.4% |
| 1 year ago | $12.35 | $494.74 | -50.5% |
| All time (5.0y) ago | $416.4 | $14.67 | -98.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCRB forecast.
Our base-case forecast reaches $12.00 around 2034.
Implied market cap at $12.00: $116.21M
The year-by-year forecast shows a path from 2026 onward with rising averages and strong upside potential. In 2026 the min is $5.62, the avg is $6.11, and the max is $8.45 (ROI 0, sentiment NEUTRAL). From 2027 to 2050 the averages rise, with 2027 at $8.33 (ROI 36.3%), 2028 at $9.51 (ROI 55.6%), 2029 at $8.55 (ROI 40%), 2030 at $8.45 (ROI 38.3%), 2031 at $8.45 (ROI 38.3%), 2032 at $8.88 (ROI 45.4%), 2033 at $10.89 (ROI 78.2%), 2034 at $12.54 (ROI 105.2%), 2035 at $13.89 (ROI 127.3%), 2040 at $17.39 (ROI 184.5%), and 2050 at $28.06 (ROI 359.2%).
The 2050 max is $64.53. Overall, the longer horizon shows a BULLISH sentiment with substantial upside potential, tempered by near-term uncertainty and high volatility.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $8.45, a low of $5.48, and a high of $14.08, with an ROI of 38.3% and bullish sentiment.
The forecast turns bullish from 2027 onward, with year-by-year averages rising to $28.06 by 2050 and ROI reaching 359.2%. Near term there is neutral sentiment in 2026 and current bearish underpinnings, so results are uncertain and not guaranteed.
Yes. The 2050 forecast includes a max of $64.53, so reaching $50 is within the projected path.
Current price is $6.11 and market cap is $59.17M.
The 30-day picture is bearish with RSI14 at 40. The stock trades between support at $5.62 and resistance at $8.14, with a 30-day range of $4.48 to $8.32. It also shows SMA50 at $7.23 and SMA200 at $12.33, and an annualized volatility of 90%.
Seres Therapeutics, Inc. Community Discussion
0Share your Seres Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.